Earnings Preview — 2821 total
GCT Semiconductor heads into its May 14 earnings report with short sellers retreating even as the borrow market signals residual caution. The most striking setup dynamic is the rapid unwinding of short positions…
Neurogene Inc. heads into its May 15 results carrying two contradictory signals: one of the most bullish options postures in the past year sits alongside a short interest level that still commands nearly a quarter of…
GUTS heads into its post-earnings session with a fresh EPS beat and a clinical story that is sharpening, even as the stock trades well below where most analysts think it belongs. The Q1 result was the clearest positive…
TriSalus Life Sciences heads into its May 14 earnings with short sellers adding positions at the fastest rate in months — yet the lending market remains far too relaxed to suggest anything close to a squeeze. Short…
Bitcoin Depot Inc. heads into its May 14 earnings print with a fractured signal set — short sellers have retreated sharply, but the borrow market remains anything but normal. The most striking development in the…
SLND heads into its May 13 earnings call after one of the most violent short-term rallies in its recent history — a 34% weekly gain that has materially changed the risk picture around the print. The stock's momentum is…
Enhabit approaches its May 14 Q1 2026 earnings report in an unusual position: short sellers are actively pulling back, yet options traders have moved sharply into defensive territory. Short interest in the home health…
System1, Inc. reports today with a borrow market that has been under extreme stress — and a stock that has just staged one of its sharpest rallies in months. The lending market tells the most charged story heading into…
HYPR heads into its Q1 2026 earnings report on May 14 riding a remarkable 43% one-month price surge — the question is whether the fundamentals can justify a stock that has nearly doubled year-to-date. Options traders…
Hour Loop heads into its Q1 2026 results with the sharpest short-interest build in the lending data — and a borrow market that has tightened dramatically around it. The standout story is the velocity of the short…
Public Policy Holding Company heads into its results today carrying one clear legacy signal: nearly every member of the senior leadership team sold shares in January, at prices well above where the stock trades…
CBL & Associates Properties reports Q1 2026 results on May 14 standing apart from its retail REIT peers — not for aggressive short positioning, but for a price rally that has left the sector behind. The most striking…
Dutch Bros reports after the bell today carrying one of the most crowded short positions in the restaurant sector heading into the print. Short interest is genuinely elevated. At roughly 15% of free float, the position…
Stran & Company heads into today's investor call with actual Q1 numbers already on the table — and they beat. The company printed Q1 EPS of $0.04, up from a loss of $0.02 a year ago. Revenue came in at $31.2 million, a…
Evolv Technologies heads into tomorrow's Q1 earnings report with a story split squarely between accelerating revenue momentum and a steady drip of insider disposals from the company's own founders. The most telling…
ASTL heads into today's Q1 2026 results with short sellers in clear retreat — the lending market and positioning data tell a coordinated story of reduced conviction on the downside. Short interest has collapsed by…
Upexi enters its May 15 earnings print carrying one of the more combustible short setups in the small-cap universe — 27% of the free float sold short, a borrow availability rate of just 27%, and a cost to borrow…
Ernexa Therapeutics walks into its May 14 earnings event with one of the most charged short-selling setups in the micro-cap biotech universe. The borrow market tells the clearest story. Cost to borrow has exploded to…
Compass, Inc. heads into its May 14 Q1 2026 earnings print carrying one of the strongest EPS momentum readings in the market — yet short sellers have quietly begun rebuilding positions over the past week. The most…
Damora Therapeutics walks into its May 14 earnings release with short sellers having nearly doubled their positions in six weeks — a striking build in a small-cap biotech that has already shed 11% over the past…
